semaglutide and cardiac risk A trial emulation in Nature Medicine shows that treatment with tirzepatide showed similar levels of benefit on cardiovascular outcomes in people at elevated cardiovascular with obesity and diabetes. Link Evaluating the Cardiovascular Benefits of

Since starting my LifeMD weight loss journey, I have experienced zero negative mental side effects

Each patients experience will be different, and the maintenance dose is decided based on how well the medication is working for them and whether they are experiencing any side effects, says Yusupov

However, because HbA1c reflects average glucose over the preceding 812 weeks, measurable changes in this parameter lag behind actual glycaemic improvements

Its about whats happening inside my body. The Numbers Tell the Story Heres what the research shows us, and what I see clinically every day: 65.5% of women aged 40 to 59 have abdominal obesity 73.8% of women aged 60+ have abdominal obesity Women gain approximately 1.5 kg per year during perimenopause Average total weight gain during the menopause transition: 10 kg (22 lbs) Visceral fat can roughly double, from 5 to 8% to 10 to 15% of total body weight In my clinical experience, these numbers feel conservative

This wrap is a perfect balance of lean protein, healthy fats, and fiber, making it a great choice for a midday meal